|
- 03 August 1960: Ha Tinh Pharmaceutical State-Owned Company was established; - 27 October 2004: Ha Tinh Provincial People's Committee issued Decision No.500/QD-UBND on transforming Ha Tinh Pharmaceutical and Medical Equipment Company into Ha Tinh Pharmaceutical and Medical Equipment Joint Stock Company; - 29 December 2004: Put into operation under the model of a joint-stock company with an initial charter capital of VND5.5 billion; - 29 January 2008: Charter capital was raised up to VND12.5 billion; - 26 December 2008: Became a public company; - 31 December 2009: Renamed as Ha Tinh Pharmaceutical Joint Stock Company with its charter capital up to VND18.75 billion; - 22 April 2011: Increased charter capital to VND33,316,740,000; - 27 June 2013: Increased charter capital to VND58,513,100,000; - Ngày 30/09/2015: SCIC sold all of their 1,395,900 shares in HADIPHAR, which accounts for 23.86% charter capital. 100% was bought by investors at an average winning bid of VND21,200 per share; - 16 March 2017: Traded on the UPCOM market; - 12 December 2017: Increased charter capital to VND61,438,100,000; - 11 May 2018: Increased charter capital to VND67,581,200,000; - 27 December 2018: Increased charter capital to VND70,931,200,000; - May 28, 2019: Increased charter capital to VND78.023.250.000; - January 20, 2020: Increased charter capital to VND81.923.250.000; - May 05, 2020: Increased charter capital to VND90.114.180.000. - September 28, 2021: Increased charter capital to VND94.614.180.000; |
